A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT07713290 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07713290
Sponsor: Beijing Gene Key Life Technology Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Cancer

Start date: 2025-04-03
Primary completion: 2026-11-12
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.